prikaz prve stranice dokumenta Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage
  Download
PDF 134.85 KB
Scientific paper - Original scientific paper
Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage
Anticancer Research, 40 (2020), 4; 2323-2329. https://doi.org/10.21873/anticanres.14199
Ovčariček, Petra Petranović; Fröbe, Ana; Verburg, Frederik Anton; Murgić, Jure; Butković, Marija Bosak; Ovčariček, Slaven; Mažuran, Berislav; Krušlin, Božo; Jakovčević, Danica; Šoipi, Šoip; Ružić, Boris; Milošević, Milan; Krilić, Dražena; Franceschi, Maja; Jukić, Tomislav More authors...

Institutional repository: University of Zagreb School of Dental Medicine Repository

Cite this document

Ovčariček, P. P., Fröbe, A., Verburg, F. A., Murgić, J., Butković, M. B., Ovčariček, S. ... Jukić, T. (2020). Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage. Anticancer Research, 40. (4), 2323-2329. doi: 10.21873/anticanres.14199

Ovčariček, Petra Petranović, et al. "Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage." Anticancer Research, vol. 40, no. 4, 2020, pp. 2323-2329. https://doi.org/10.21873/anticanres.14199

Ovčariček, Petra Petranović, Ana Fröbe, Frederik Anton Verburg, Jure Murgić, Marija Bosak Butković, Slaven Ovčariček, Berislav Mažuran, et al. "Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage." Anticancer Research 40, no. 4 (2020): 2323-2329. https://doi.org/10.21873/anticanres.14199

Ovčariček, P. P., et al. (2020) 'Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage', Anticancer Research, 40(4), pp. 2323-2329. doi: 10.21873/anticanres.14199

Ovčariček PP, Fröbe A, Verburg FA, Murgić J, Butković MB, Ovčariček S, and sur.. Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage. Anticancer Research [Internet]. 2020 March 31 [cited 2024 November 22];40(4):2323-2329. doi: 10.21873/anticanres.14199

P. P. Ovčariček, et al., "Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage", Anticancer Research, vol. 40, no. 4, pp. 2323-2329, March 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:127:784774. [Accessed: 22 November 2024]

Metadata
Title (english)Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage
AuthorPetra Petranović Ovčariček
AuthorAna Fröbe
AuthorFrederik Anton Verburg
AuthorJure Murgić
AuthorMarija Bosak Butković
AuthorSlaven Ovčariček
AuthorBerislav Mažuran
AuthorBožo Krušlin
AuthorDanica Jakovčević
AuthorŠoip Šoipi
AuthorBoris Ružić
AuthorMilan Milošević
AuthorDražena Krilić
AuthorMaja Franceschi
AuthorTomislav Jukić
Author's institutionUniversity of Applied Health Sciences
Author's institution(Sv. Duh University Hospital)
Author's institution(Sestre milosrdnice University Hospital Center)
Author's institutionUniversity of Zagreb
School of Dental Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Background/Aim: The aim of this study was to determine the association between total triiodothyronine (T3), free fraction of thyroxin (FT4), and thyrotropin (TSH) levels with prostate cancer histopathological features. Patients and Methods: Blood samples from 140 patients with prostate cancer were analyzed preoperatively and stratified according to postoperative histopathological differentiation. The first group (N=62) included patients with prostate cancer Grade Groups (GG) 1-2, while the second group (N=63) included patients with prostate cancer GG 3-5. Results: T3 levels were significantly higher in patients with prostate cancer GG 3-5 (p=0.047). There was no significant difference in the FT4 and TSH levels between the two groups (p=0.680 and 0.801, respectively). T3 levels were positively correlated with tumor percentage involvement (TPI) (p=0.002), and pT stage (p=0.047) on definitive pathology. Conclusion: Higher T3 levels are associated with several indicators of prostate cancer histopathological aggressiveness.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleAnticancer Research
Numberingvol. 40, no. 4, pp. 2323-2329
p-ISSN0250-7005
e-ISSN1791-7530
DOIhttps://doi.org/10.21873/anticanres.14199
URN:NBNurn:nbn:hr:127:784774
Publication2020-03-31
Document URLhttp://ar.iiarjournals.org/lookup/doi/10.21873/anticanres.14199
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-10-23 10:46:01